Dia A. Smiley - Publications

Sodium-glucose cotransporter-2 inhibitor therapy and body composition analysis in transthyretin amyloid cardiomyopathy: a prospective, feasibility pilot study.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: September 08, 2026

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

Journal: JAMA

Published: August 30, 2026

"The Future Is Bright and Speckled" as We Explore Our Collective Experience Regarding Fellowships Completed in Subspecialty Cardiac Amyloidosis Centers.

Journal: Journal of cardiac failure

Published: December 08, 2025

Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis: Prevalence, Incidence, Clinical Predictors, and Effect of Tafamidis.

Journal: JACC. Advances

Published: October 03, 2025

Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure.

Journal: JAMA cardiology

Published: September 10, 2025

From the Bone Marrow to the Heart: Cardiac Recovery in AL Amyloidosis.

Journal: JACC. Asia

Published: January 31, 2025

The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study.

Journal: The American journal of cardiology

Published: September 16, 2024

Cardiac disease monitoring measures in patients with transthyretin amyloid cardiomyopathy treated with tafamidis.

Journal: Heart (British Cardiac Society)

Published: August 02, 2024

Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography/Computed Tomography.

Journal: JACC. Cardiovascular imaging

Published: June 27, 2024

Impact of Anemia on Mortality and Morbidity in Transthyretin Amyloid Cardiomyopathy.

Journal: The American journal of cardiology

Published: May 01, 2024

Temporal Outcomes of Patients Diagnosed With Transthyretin Cardiac Amyloidosis.

Journal: Journal of cardiac failure

Published: September 18, 2023

Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy.

Journal: Circulation. Cardiovascular imaging

Published: June 19, 2023